Veterinary Medicines

Phenosan 50 mg chewable tablets for dogs

Authorised
  • Phenobarbital
Download as PDF

Product identification

Medicine name:
Phenosan 50 mg chewable tablets for dogs
Phenosan 50 mg compresse masticabili per cani
Active substance:
  • Phenobarbital
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Phenobarbital
    50.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Chewable tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QN03AA02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Italy
Package description:
  • PVDC/PE/PVC-PVC/Aluminium/Paper blister containing 10 chewable tablets. Carton box containing 10 chewable tablets.
  • PVDC/PE/PVC-PVC/Aluminium/Paper blister containing 10 chewable tablets. Carton box containing 20 chewable tablets.
  • PVDC/PE/PVC-PVC/Aluminium/Paper blister containing 10 chewable tablets. Carton box containing 30 chewable tablets.
  • PVDC/PE/PVC-PVC/Aluminium/Paper blister containing 10 chewable tablets. Carton box containing 40 chewable tablets.
  • PVDC/PE/PVC-PVC/Aluminium/Paper blister containing 10 chewable tablets. Carton box containing 50 chewable tablets.
  • PVDC/PE/PVC-PVC/Aluminium/Paper blister containing 10 chewable tablets. Carton box containing 60 chewable tablets.
  • PVDC/PE/PVC-PVC/Aluminium/Paper blister containing 10 chewable tablets. Carton box containing 70 chewable tablets.
  • PVDC/PE/PVC-PVC/Aluminium/Paper blister containing 10 chewable tablets. Carton box containing 80 chewable tablets.
  • PVDC/PE/PVC-PVC/Aluminium/Paper blister containing 10 chewable tablets. Carton box containing 100 chewable tablets.
  • PVDC/PE/PVC-PVC/Aluminium/Paper blister containing 10 chewable tablets. Carton box containing 250 chewable tablets.
  • PVC/PE/PVDC-PVC/Aluminium/Paper blister containing 10 chewable tablets. Carton box containing 90 chewable tablets.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Bibliographic application (Article 22 of Regulation (EU) 2019/6)
Marketing authorisation holder:
  • Alfasan Nederland B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Alfasan Nederland B.V.
Responsible authority:
  • European Medicines Agency
Authorisation number:
  • 105802
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0396/002
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Croatia
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Iceland
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Italian (PDF)
Published on: 8/06/2025
Download